Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles. - Wikidata - awgldk - TriplyDB

Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles.

Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles.

http://www.wikidata.org/entity/Q33817609

about

Antibody PEGylation in bioorthogonal pretargeting with trans-cyclooctene/tetrazine cycloaddition: in vitro and in vivo evaluation in colorectal cancer models.Pretargeting of internalizing trastuzumab and cetuximab with a 18F-tetrazine tracer in xenograft models.

P2860

Q44384601-F7FEF7C1-BB57-4DC2-9117-7F567F003AF9 Q47095216-38495362-C737-4594-91C6-433461151227

P2860

Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles.

http://www.wikidata.org/entity/Q33817609

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles.

@ast

Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles.

@en

type

label

Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles.

@ast

Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles.

@en

prefLabel

Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles.

@ast

Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles.

@en

P1433

Q33817609-A211DFE7-2093-4A98-92A4-45899101296B

P1476

Q33817609-4EB12172-6C4C-4FDB-A133-3157C79A8068

P2093

Q33817609-1DC9D2B2-4E06-4FA6-8203-593FD23D275E

Q33817609-5748285C-CC5F-4BC7-8F74-701281870605

Q33817609-5DA4F1CA-CFAA-4943-AEDA-344F742E7266

Q33817609-88019597-E892-42CB-9D67-62156213A318

Q33817609-DE1C0ACC-091C-4979-A6D0-71758122F48E

P2860

Q33817609-0D222D3D-E8A9-4AC1-9E69-E4D31A8C9B72

Q33817609-169B65D6-0557-4754-8884-8D12BFBFC541

Q33817609-22DE1F5B-A653-41BD-95EB-9D94D2AF740C

Q33817609-2AD8F00B-F7C2-42D8-A167-A5E94000D204

Q33817609-32EEF65A-147F-473C-9B1C-0B2B4F85C782

Q33817609-3CD41B0A-26B9-4DDA-B121-2D154EF16FFB

Q33817609-3E4040A1-0C8E-4CFA-8384-AAA9F59988E6

Q33817609-3E548B64-E8B3-4A46-9F85-B8BA04C14530

Q33817609-42B8F296-7CD2-4E3F-8CD5-BA5F0D3E099D

Q33817609-4B7DCB7E-60B4-44F1-A1A1-68B7EF808F98

P304

Q33817609-883129E0-1A61-4DC7-8D39-D29640F119EC

P31

Q33817609-C7B0F541-3054-4454-9102-089430238091

P356

Q33817609-60959961-F3E6-4274-8675-DDB92DAD28DD

P433

Q33817609-7E66C5CB-6809-4033-ACD6-FCCFCF19E6F0

P478

Q33817609-819F955D-DB80-48D8-9F2B-790FCE3FB527

P50

Q33817609-254693E3-DB86-4939-8949-A160717E3A48

Q33817609-26FCF8D7-65B7-4B38-BA8A-9BE59379CF0A

Q33817609-66CA9308-C55E-45DE-83CD-153DD62E5CC3

Q33817609-9DAFEED4-8B7F-4BE3-B8ED-A857762F524A

Q33817609-B6F22F4B-7697-4EDA-B1B0-8226E7A3B77D

Q33817609-B8AC7A4A-CBA9-4816-BB6D-2B5DDA96EA37

Q33817609-CC8FA5C1-2A35-4BF3-8E50-D6118A7E3E83

P577

Q33817609-94D5AC6F-1A95-4323-AF56-7228176F4364

P698

Q33817609-42EF0090-DBF7-47C7-B1A8-13684F012C54

P932

Q33817609-2032A20E-1BC8-4BB9-8980-B8980035F0E3

P356

ACSOMEGA.6B00269

P1433

P1476

Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles.

@en

P2093

Albert D Windhorst

http://www.w3.org/2001/XMLSchema#string

Carla Molthoff

http://www.w3.org/2001/XMLSchema#string

Helena Virtanen

http://www.w3.org/2001/XMLSchema#string

Jarno J Salonen

http://www.w3.org/2001/XMLSchema#string

Rici Lindgren

http://www.w3.org/2001/XMLSchema#string

P2860

Bioorthogonal chemistry: fishing for selectivity in a sea of functionality

The journey of a drug-carrier in the body: an anatomo-physiological perspective

Pretargeted Positron Emission Tomography Imaging That Employs Supramolecular Nanoparticles with in Vivo Bioorthogonal Chemistry

From mechanism to mouse: a tale of two bioorthogonal reactions

Reactive polymer enables efficient in vivo bioorthogonal chemistry.

Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.

Mesoporous silicon in drug delivery applications.

Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.

Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rate.

Enhancing reactivity for bioorthogonal pretargeting by unmasking antibody-conjugated trans-cyclooctenes.

P304

62-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSOMEGA.6B00269

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Anu J Airaksinen

Mirkka Sarparanta

Heidi Liljenbäck

P577

2017-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28649670

http://www.w3.org/2001/XMLSchema#string

P932

5478181

http://www.w3.org/2001/XMLSchema#string